KROS - Financial Reports List - Keros Therapeutics, Inc. - IntrinsicAlpha

Keros Therapeutics, Inc. KROS

Healthcare - Biotechnology - NASDAQ - US

$ 14.04

-0.707 %

$ 570 M

Market Cap

-82.59

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	254413.25%	444.32%	413.59%
Quarterly Report	Q4	8-K	2024-12-31	2027.27%	-14.37%	-14.64%
Annual Report	FY	10-K	2024-12-31	2250.99%	-22.46%	-24.06%
Quarterly Report	Q3	8-K	2024-09-30	4750.00%	-34.27%	-35.53%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-20.67%	-22.02%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-31.69%	-24.73%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-35.41%	-45.35%
Annual Report	FY	10-K	2023-12-31	0.00%	-46.15%	-48.05%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-107.12%	-54.70%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-57.56%	-34.53%

1